Web Access Research Portal

Researcher: Bezabhe, W (Dr Woldesellassie Bezabhe)

Fields of Research

Clinical pharmacy and pharmacy practice
Clinical pharmacology and therapeutics
Cardiology (incl. cardiovascular diseases)
Primary health care
Epidemiology
Cardiovascular medicine and haematology
Infectious diseases
Anaesthesiology
Traditional, complementary and integrative medicine
Surgery
Virology
Aged health care

Research Objectives

Clinical health
Other health
Efficacy of medications
Diagnosis of human diseases and conditions
Prevention of human diseases and conditions
Evaluation of health outcomes
Treatment of human diseases and conditions
Evaluation of health and support services
Provision of health and support services
Primary care
Expanding knowledge in the health sciences
Behaviour and health
Health education and promotion

Career Best Publications

Research Publications

Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol; BMJ Open
Adherence to antiretroviral therapy and virologic failure; Medicine
Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: a prospective cohort study from Ethiopia; Drug Safety
Antiretroviral adherence and treatment outcomes among adult Ethiopian patients; 2015 Joint APSA-ASCEPT Annual Conference
Antiretroviral adherence and treatment outcomes among adult Ethiopian patients; Aids Care
Antiretroviral adherence and treatment outcomes among adult Ethiopian patients; 2015 Joint APSA-ASCEPT Annual Conference
Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial Fibrillation; Clinical Medicine Insights: Cardiology
Authors’ Reply to Cotton and Nicol’s Comment on ‘‘Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia’’; Drug Safety
Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia; PLoS One
Can DOACs protect patients with AF from dementia?; InSight
Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension; Journal of Human Hypertension
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants; Expert Review of Clinical Pharmacology
Comparison of renin-angiotensin-aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes; BMC Infectious Diseases
Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis; JAC - Antimicrobial Resistance
COVID-19 in Ethiopia: A geospatial analysis of vulnerability to infection, case severity and death; BMJ Open
Development and Validation of an Atrial Fibrillation Knowledge Assessment Tool (AFKAT); International Journal of Environmental Research and Public Health
Effect of a fucoidan extract on insulin resistance and cardiometabolic markers in obese, nondiabetic subjects: a randomized, controlled trial; Journal of Alternative and Complementary Medicine
Eight-year trends in direct-acting oral anticoagulant dosing, based on age and kidney function, in patients with atrial fibrillation; Journal of Patient Safety
Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: A case-control study from Ethiopia; BMC Infectious Diseases
Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation; European Journal of Clinical Investigation
Five-year trends in potential drug interactions with direct-acting oral anticoagulants in patients with atrial fibrillation: an Australian-wide study; Journal of Clinical Medicine
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019; The Lancet Neurology
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019; The Lancet HIV
Improving knowledge and early detection of atrial fibrillation through a community-based opportunistic screening program: what's your beat?; International Journal of Environmental Research and Public Health
Incidence of Osteoporosis in Primary Care Patients with atrial fibrillation receiving different oral anticoagulants; Journal of Clinical Medicine
Medication prescribing quality in Australian primary care patients with chronic kidney disease; Journal of Clinical Medicine
Oral anticoagulant discontinuation and its predictors in patients with atrial fibrillation; Journal of Clinical Medicine
Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population-based cohort study; Journal of the American Heart Association
Quality use of medicines in patients with chronic kidney disease; BMC Nephrology
Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapy; Expert Review of Clinical Pharmacology
Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: a ten-year follow-up; European Journal of Clinical Investigation
Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study; The Lancet HIV
Switching of oral anticoagulants in atrial fibrillation: a cohort study using Australian general practice data; Expert Review of Clinical Pharmacology
Switching of oral anticoagulants in patients with nonvalvular atrial fibrillation: A narrative review; British Journal of Clinical Pharmacology
Ten-year trends in prescribing of antiarrhythmic drugs in Australian primary care patients with atrial fibrillation; Internal Medicine Journal
Ten-Year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation; Frontiers in Pharmacology
The COVID-19 pandemic and healthcare systems in Africa: A scoping review of preparedness, impact and response; BMJ Global Health
The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community; Journal of Antimicrobial Chemotherapy

Research Projects

Hospitalisation as an opportunity to optimise anticoagulant treatment in patients with atrial fibrillation; Royal Hobart Hospital Research Foundation (RHHRF)
Intervention to lessen anticholinergic drug burden in hospitalised older adults; Royal Hobart Hospital Research Foundation (RHHRF)

Research Candidate Supervision